Intended for healthcare professionals


Indian campaigners ask government to stop relying on handouts of bedaquiline to ensure supply

BMJ 2019; 365 doi: (Published 09 May 2019) Cite this as: BMJ 2019;365:l2140

Health and patients’ rights groups have asked India’s health ministry to stop depending on donations of bedaquiline from Johnson and Johnson to treat patients with multidrug resistant tuberculosis (MDR-TB) and instead use its own funds to procure the drug.

In a letter sent to the health ministry last week, the All India Drug Action Network (AIDAN), a consortium of physicians and health activists, and other groups said dependence on “piecemeal donations” threatened the sustainability and predictability of the government’s plan to treat patients with MDR-TB.

They have asked the government to phase out donated bedaquiline and find and treat all patients in India eligible for the bedaquiline based regimen through its domestic budget.

The …

View Full Text

Log in

Log in through your institution


* For online subscription